Article

Atrial Ectopy as a Predictor of Incident Atrial Fibrillation

University of California, San Francisco, San Francisco, California, United States
Annals of internal medicine (Impact Factor: 17.81). 12/2013; 159(11):721-8. DOI: 10.7326/0003-4819-159-11-201312030-00004
Source: PubMed

ABSTRACT

Atrial fibrillation (AF) prediction models have unclear clinical utility given the absence of AF prevention therapies and the immutability of many risk factors. Premature atrial contractions (PACs) play a critical role in AF pathogenesis and may be modifiable.
To investigate whether PAC count improves model performance for AF risk.
Prospective cohort study.
4 U.S. communities.
A random subset of 1260 adults without prevalent AF enrolled in the Cardiovascular Health Study between 1989 and 1990.
The PAC count was quantified by 24-hour electrocardiography. Participants were followed for the diagnosis of incident AF or death. The Framingham AF risk algorithm was used as the comparator prediction model.
In adjusted analyses, doubling the hourly PAC count was associated with a significant increase in AF risk (hazard ratio, 1.17 [95% CI, 1.13 to 1.22]; P < 0.001) and overall mortality (hazard ratio, 1.06 [CI, 1.03 to 1.09]; P < 0.001). Compared with the Framingham model, PAC count alone resulted in similar AF risk discrimination at 5 and 10 years of follow-up and superior risk discrimination at 15 years. The addition of PAC count to the Framingham model resulted in significant 10-year AF risk discrimination improvement (c-statistic, 0.65 vs. 0.72; P < 0.001), net reclassification improvement (23.2% [CI, 12.8% to 33.6%]; P < 0.001), and integrated discrimination improvement (5.6% [CI, 4.2% to 7.0%]; P < 0.001). The specificity for predicting AF at 15 years exceeded 90% for PAC counts more than 32 beats/h.
This study does not establish a causal link between PACs and AF.
The addition of PAC count to a validated AF risk algorithm provides superior AF risk discrimination and significantly improves risk reclassification. Further study is needed to determine whether PAC modification can prospectively reduce AF risk.
American Heart Association, Joseph Drown Foundation, and National Institutes of Health.

Download full-text

Full-text

Available from: Phyllis K Stein, Nov 16, 2015

  • No preview · Article · Dec 2013 · Annals of internal medicine
  • [Show abstract] [Hide abstract]
    ABSTRACT: Atrial fibrillation remains the most prevalent cardiac arrhythmia, and its incidence is increasing as the population ages. Common conditions associated with an increased incidence include advanced age, hypertension, heart failure, and valvular heart disease. Patients with atrial fibrillation may complain of palpitations, fatigue, and decreased exercise tolerance or may be completely asymptomatic. Options for treating patients who experience atrial fibrillation include rate-controlling drugs such as digoxin, β-blockers, and calcium channel blockers or a rhythm-controlling strategy with agents such as sodium channel blockers and potassium channel blockers. Atrial fibrillation increases the risk of stroke due to atrial thrombus formation and embolization. Anticoagulation with the vitamin K antagonist, warfarin, remains the most widely prescribed treatment option to decrease stroke risk. Several other antithrombotic agents have recently become available and offer excellent alternatives to warfarin. Catheter ablation can be undertaken as a nonpharmacologic rhythm control option with varying degrees of success depending on duration of atrial fibrillation and follow-up time from the procedure. This review article further describes the management options for patients presenting with atrial fibrillation.
    No preview · Article · May 2014 · Journal of Intensive Care Medicine
  • [Show abstract] [Hide abstract]
    ABSTRACT: Premature ectopic beats are frequently detected on routine 12-lead screening-electrocardiogram (ECG). However, their prognostic importance in individuals without known cardiovascular disease (CVD) is not well established. We evaluated prognostic value of atrial premature complexes (APC’s) and ventricular premature complexes (VPC’s) detected by a single 12-lead-ECG. A prospective cohort of 7504 participants selected from nationally-representative, community-dwelling individuals living in United States, enrolled in the Third Health and Nutrition Examination Survey (NHANES-III) from 1988 – 94 with follow up through December 2006 without known CVD. The main outcomes were all – cause mortality, CVD related mortality and IHD related mortality. Out of 7504 participants (mean age 60 ± 14 years, 47% women, 49% whites), 89 (1.2%) had APC’s and 110 (1.5%) had VPC’s on 12 – lead ECG. During a follow up of up to 18 years, 2386 deaths occurred, of which 963 were due to CVD and 511 were due to IHD. In a multivariable adjusted for demographics, clinical variables and ECG measures, APC’s were significantly associated with all-cause mortality [HR, 1.41 (95% CI, 1.08-1.80)], CVD death [HR, 1.78 (95% CI, 1.26-2.44)] and IHD death [HR, 2.40 (95% CI, 1.59-3.47)]. For VPCs, however, there were no significant associations with all – cause mortality [HR, 1.05 (95% CI, 0.80-1.36)], CVD death [HR, 0.96 (95% CI, 0.62-1.43)] and IHD death [HR, 0.89 (95% CI, 0.47-1.52)]. In conclusion, APC’s, but not VPC’s, on routine screening ECG are predictive of adverse events in community-dwelling individuals without known CVD.
    No preview · Article · Jul 2014 · The American journal of cardiology
Show more